7 unknown. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Unknown 7 |
| Phase 2 | 3 | Unknown 3 |
Follow Dyskinesias: new trials by email Literature Review of Dyskinesias trials Research Report on Dyskinesias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of NestaCell® in Huntington's Disease NestaCell® - Huntington Disease | Phase 3 | Unknown | Azidus Brasil | 120 | 2024-06-08 | 2023-10-24 |
| Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients. Cellavita-HD - Huntington Disease | Phase 2 / Phase 3 | Unknown | Azidus Brasil | 35 | 2020-02-10 | 2022-10-28 |
| A Study of Staccato Loxapine (ADASUVE®) for Inhalation Inhaled loxapine, Inhaled placebo - Psychomotor Agitation, Schizophrenia | Phase 3 | Unknown | Lee's Pharmaceutical Limited | 150 | 2019-12-01 | 2019-11-05 |
| Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103) RP103, Placebo - Huntington's Disease | Phase 2 / Phase 3 | Unknown | University Hospital, Angers | 96 | 2010-10-01 | 2014-04-02 |
| Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor 123 I - ALTROPANE® - Parkinsonian Syndromes | Phase 3 | Unknown | Alseres Pharmaceuticals, Inc | 240 | 2010-07-01 | 2010-02-03 |
| Bilateral Internal Pallidum Stimulation in Primary Generalized Dystonia deep brain stimulation of the internal globus pallidus - Dystonia, Primary Generalized Dystonia | Phase 2 / Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 24 | 2005-02-01 | 2006-01-05 |
| Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia Deep brain stimulation - Dystonia | Phase 3 | Unknown | Groupe Hospitalier Pitie-Salpetriere | 2007-08-29 |
Huntington Disease (3) · Dystonia (2) · Bipolar Disorder (1) · Disease (1) · Essential Tremor (1) · Parkinson Disease (1) · Parkinsonian Disorders (1) · Psychomotor Agitation (1) · Schizophrenia (1) · Tremor (1)
Nervous System Diseases (7) · Basal Ganglia Diseases (4) · Brain Diseases (4) · Central Nervous System Diseases (4) · Mental Disorders (4) · Movement Disorders (4) · Neurodegenerative Diseases (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Chorea (3) · Cognition Disorders (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Dementia (3)
Cell- and Tissue-Based Therapy (1) · Deep Brain Stimulation (1) · Loxapine (1)
Azidus Brasil (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Alseres Pharmaceuticals, Inc (1) · Groupe Hospitalier Pitie-Salpetriere (1) · Lee's Pharmaceutical Limited (1) · University Hospital, Angers (1)
France (2) · Brazil (1) · Netherlands (1) · United States (1)
Hans Speelman, PhD (1) · Joyce Macedo, MD (1) · Luciana Ferrara, Doctor (1) · Marie Vidailhet, MD, PhD (1)